These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 37534479

  • 1. Current State of Lipid Nanoparticles (SLN and NLC) for Skin Applications.
    Eroğlu C, Sinani G, Ulker Z.
    Curr Pharm Des; 2023; 29(21):1632-1644. PubMed ID: 37534479
    [Abstract] [Full Text] [Related]

  • 2. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
    Müller RH, Radtke M, Wissing SA.
    Adv Drug Deliv Rev; 2002 Nov 01; 54 Suppl 1():S131-55. PubMed ID: 12460720
    [Abstract] [Full Text] [Related]

  • 3. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals.
    Puglia C, Bonina F.
    Expert Opin Drug Deliv; 2012 Apr 01; 9(4):429-41. PubMed ID: 22394125
    [Abstract] [Full Text] [Related]

  • 4. Natural Lipids as Structural Components of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Topical Delivery.
    Dobreva M, Stefanov S, Andonova V.
    Curr Pharm Des; 2020 Apr 01; 26(36):4524-4535. PubMed ID: 32410552
    [Abstract] [Full Text] [Related]

  • 5. Nanostructured lipid carriers (NLC) in cosmetic dermal products.
    Müller RH, Petersen RD, Hommoss A, Pardeike J.
    Adv Drug Deliv Rev; 2007 Jul 10; 59(6):522-30. PubMed ID: 17602783
    [Abstract] [Full Text] [Related]

  • 6. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
    Pardeike J, Hommoss A, Müller RH.
    Int J Pharm; 2009 Jan 21; 366(1-2):170-84. PubMed ID: 18992314
    [Abstract] [Full Text] [Related]

  • 7. SLN and NLC for topical, dermal, and transdermal drug delivery.
    Souto EB, Baldim I, Oliveira WP, Rao R, Yadav N, Gama FM, Mahant S.
    Expert Opin Drug Deliv; 2020 Mar 21; 17(3):357-377. PubMed ID: 32064958
    [Abstract] [Full Text] [Related]

  • 8. Cosmetic features and applications of lipid nanoparticles (SLN, NLC).
    Souto EB, Müller RH.
    Int J Cosmet Sci; 2008 Jun 21; 30(3):157-65. PubMed ID: 18452432
    [Abstract] [Full Text] [Related]

  • 9. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.
    Garcês A, Amaral MH, Sousa Lobo JM, Silva AC.
    Eur J Pharm Sci; 2018 Jan 15; 112():159-167. PubMed ID: 29183800
    [Abstract] [Full Text] [Related]

  • 10. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.
    Gokce EH, Korkmaz E, Dellera E, Sandri G, Bonferoni MC, Ozer O.
    Int J Nanomedicine; 2012 Jan 15; 7():1841-50. PubMed ID: 22605933
    [Abstract] [Full Text] [Related]

  • 11. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
    Mitri K, Shegokar R, Gohla S, Anselmi C, Müller RH.
    Int J Pharm; 2011 Jul 29; 414(1-2):267-75. PubMed ID: 21596122
    [Abstract] [Full Text] [Related]

  • 12. Heptapeptide-loaded solid lipid nanoparticles for cosmetic anti-aging applications.
    Suter F, Schmid D, Wandrey F, Zülli F.
    Eur J Pharm Biopharm; 2016 Nov 29; 108():304-309. PubMed ID: 27343822
    [Abstract] [Full Text] [Related]

  • 13. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
    Fang JY, Fang CL, Liu CH, Su YH.
    Eur J Pharm Biopharm; 2008 Oct 29; 70(2):633-40. PubMed ID: 18577447
    [Abstract] [Full Text] [Related]

  • 14. Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles.
    Andrade LM, de Fátima Reis C, Maione-Silva L, Anjos JL, Alonso A, Serpa RC, Marreto RN, Lima EM, Taveira SF.
    Eur J Pharm Biopharm; 2014 Sep 29; 88(1):40-7. PubMed ID: 24816130
    [Abstract] [Full Text] [Related]

  • 15. Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion.
    Loo Ch, Basri M, Ismail R, Lau H, Tejo B, Kanthimathi M, Hassan H, Choo Y.
    Int J Nanomedicine; 2013 Sep 29; 8():13-22. PubMed ID: 23293516
    [Abstract] [Full Text] [Related]

  • 16. Development of lipid nanoparticles for transdermal loteprednol etabonate delivery.
    Üner B, Özdemir S, Taş Ç, Özsoy Y, Üner M.
    J Microencapsul; 2022 Jun 29; 39(4):327-340. PubMed ID: 35583383
    [Abstract] [Full Text] [Related]

  • 17. Solid lipid nanoparticles and nanostructured lipid carriers--innovative generations of solid lipid carriers.
    Shidhaye SS, Vaidya R, Sutar S, Patwardhan A, Kadam VJ.
    Curr Drug Deliv; 2008 Oct 29; 5(4):324-31. PubMed ID: 18855604
    [Abstract] [Full Text] [Related]

  • 18. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study.
    Arora R, Katiyar SS, Kushwah V, Jain S.
    Expert Opin Drug Deliv; 2017 Feb 29; 14(2):165-177. PubMed ID: 27882780
    [Abstract] [Full Text] [Related]

  • 19. Primaquine Loaded Solid Lipid Nanoparticles (SLN), Nanostructured Lipid Carriers (NLC), and Nanoemulsion (NE): Effect of Lipid Matrix and Surfactant on Drug Entrapment, in vitro Release, and ex vivo Hemolysis.
    Wu KW, Sweeney C, Dudhipala N, Lakhani P, Chaurasiya ND, Tekwani BL, Majumdar S.
    AAPS PharmSciTech; 2021 Sep 29; 22(7):240. PubMed ID: 34590195
    [Abstract] [Full Text] [Related]

  • 20. Are lipid nanoparticles really superior? A holistic proof of concept study.
    Wiemann S, Keck CM.
    Drug Deliv Transl Res; 2022 Jun 29; 12(6):1433-1444. PubMed ID: 34476767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.